nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CHRNA5—chronic obstructive pulmonary disease	0.277	0.575	CbGaD
Nicotine—CHRNA3—chronic obstructive pulmonary disease	0.13	0.269	CbGaD
Nicotine—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.0553	0.18	CbGbCtD
Nicotine—CYP1A1—chronic obstructive pulmonary disease	0.0384	0.0796	CbGaD
Nicotine—CYP1A2—chronic obstructive pulmonary disease	0.037	0.0767	CbGaD
Nicotine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0312	0.102	CbGbCtD
Nicotine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0266	0.0869	CbGbCtD
Nicotine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0266	0.0869	CbGbCtD
Nicotine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0202	0.0659	CbGbCtD
Nicotine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0149	0.0488	CbGbCtD
Nicotine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0118	0.0387	CbGbCtD
Nicotine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.011	0.036	CbGbCtD
Nicotine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.011	0.036	CbGbCtD
Nicotine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.00995	0.0325	CbGbCtD
Nicotine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.00916	0.0299	CbGbCtD
Nicotine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.00916	0.0299	CbGbCtD
Nicotine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00865	0.0282	CbGbCtD
Nicotine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00838	0.0273	CbGbCtD
Nicotine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00838	0.0273	CbGbCtD
Nicotine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00747	0.0244	CbGbCtD
Nicotine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00703	0.0229	CbGbCtD
Nicotine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00694	0.0227	CbGbCtD
Nicotine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00475	0.0155	CbGbCtD
Nicotine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00463	0.0151	CbGbCtD
Nicotine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00453	0.0148	CbGbCtD
Nicotine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00404	0.0132	CbGbCtD
Nicotine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00237	0.00773	CbGbCtD
Nicotine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00224	0.0073	CbGbCtD
Nicotine—CYP2A13—respiratory system—chronic obstructive pulmonary disease	0.00217	0.122	CbGeAlD
Nicotine—CYP2A13—lung—chronic obstructive pulmonary disease	0.00115	0.065	CbGeAlD
Nicotine—CHRNA3—respiratory system—chronic obstructive pulmonary disease	0.000785	0.0443	CbGeAlD
Nicotine—CHRNB2—bronchus—chronic obstructive pulmonary disease	0.000666	0.0376	CbGeAlD
Nicotine—CHRNB2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000652	0.0368	CbGeAlD
Nicotine—CHRFAM7A—respiratory system—chronic obstructive pulmonary disease	0.000635	0.0358	CbGeAlD
Nicotine—CHRNB2—trachea—chronic obstructive pulmonary disease	0.000598	0.0338	CbGeAlD
Nicotine—CHRNA4—respiratory system—chronic obstructive pulmonary disease	0.000506	0.0286	CbGeAlD
Nicotine—CHRFAM7A—trachea—chronic obstructive pulmonary disease	0.000469	0.0265	CbGeAlD
Nicotine—SLC22A4—respiratory system—chronic obstructive pulmonary disease	0.000449	0.0253	CbGeAlD
Nicotine—CHRNB2—lung—chronic obstructive pulmonary disease	0.00043	0.0243	CbGeAlD
Nicotine—CHRNA3—lung—chronic obstructive pulmonary disease	0.000417	0.0235	CbGeAlD
Nicotine—CHRNA4—bronchus—chronic obstructive pulmonary disease	0.000416	0.0235	CbGeAlD
Nicotine—MAOB—respiratory system—chronic obstructive pulmonary disease	0.000378	0.0213	CbGeAlD
Nicotine—SLC22A4—bronchus—chronic obstructive pulmonary disease	0.00037	0.0209	CbGeAlD
Nicotine—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.00036	0.0203	CbGeAlD
Nicotine—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.000354	0.02	CbGeAlD
Nicotine—MAOB—connective tissue—chronic obstructive pulmonary disease	0.000333	0.0188	CbGeAlD
Nicotine—SLC22A4—trachea—chronic obstructive pulmonary disease	0.000332	0.0187	CbGeAlD
Nicotine—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000329	0.0186	CbGeAlD
Nicotine—MAOA—respiratory system—chronic obstructive pulmonary disease	0.000323	0.0182	CbGeAlD
Nicotine—MAOB—bronchus—chronic obstructive pulmonary disease	0.000311	0.0176	CbGeAlD
Nicotine—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.000297	0.0168	CbGeAlD
Nicotine—MAOA—connective tissue—chronic obstructive pulmonary disease	0.000284	0.016	CbGeAlD
Nicotine—CYP2A6—lung—chronic obstructive pulmonary disease	0.000272	0.0154	CbGeAlD
Nicotine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000269	0.0152	CbGeAlD
Nicotine—CHRNA4—lung—chronic obstructive pulmonary disease	0.000269	0.0152	CbGeAlD
Nicotine—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000266	0.015	CbGeAlD
Nicotine—MAOA—bronchus—chronic obstructive pulmonary disease	0.000266	0.015	CbGeAlD
Nicotine—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000258	0.0146	CbGeAlD
Nicotine—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000245	0.0138	CbGeAlD
Nicotine—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000242	0.0137	CbGeAlD
Nicotine—SLC22A4—lung—chronic obstructive pulmonary disease	0.000238	0.0135	CbGeAlD
Nicotine—MAOA—trachea—chronic obstructive pulmonary disease	0.000238	0.0135	CbGeAlD
Nicotine—SLC22A5—trachea—chronic obstructive pulmonary disease	0.00022	0.0124	CbGeAlD
Nicotine—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000219	0.0123	CbGeAlD
Nicotine—SLC22A3—lung—chronic obstructive pulmonary disease	0.000217	0.0122	CbGeAlD
Nicotine—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000212	0.012	CbGeAlD
Nicotine—MAOB—lung—chronic obstructive pulmonary disease	0.000201	0.0113	CbGeAlD
Nicotine—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000196	0.0111	CbGeAlD
Nicotine—MAOA—lung—chronic obstructive pulmonary disease	0.000171	0.00967	CbGeAlD
Nicotine—SLC22A5—lung—chronic obstructive pulmonary disease	0.000158	0.00891	CbGeAlD
Nicotine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000143	0.00807	CbGeAlD
Nicotine—CYP1A1—lung—chronic obstructive pulmonary disease	0.000141	0.00796	CbGeAlD
Nicotine—CYP2B6—lung—chronic obstructive pulmonary disease	0.000137	0.00773	CbGeAlD
Nicotine—CYP2E1—lung—chronic obstructive pulmonary disease	0.000129	0.00726	CbGeAlD
Nicotine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00139	CcSEcCtD
Nicotine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00138	CcSEcCtD
Nicotine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00138	CcSEcCtD
Nicotine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00138	CcSEcCtD
Nicotine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00138	CcSEcCtD
Nicotine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.00138	CcSEcCtD
Nicotine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.00138	CcSEcCtD
Nicotine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00138	CcSEcCtD
Nicotine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00137	CcSEcCtD
Nicotine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00137	CcSEcCtD
Nicotine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00136	CcSEcCtD
Nicotine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00136	CcSEcCtD
Nicotine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00136	CcSEcCtD
Nicotine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00136	CcSEcCtD
Nicotine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00136	CcSEcCtD
Nicotine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00136	CcSEcCtD
Nicotine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00135	CcSEcCtD
Nicotine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.00135	CcSEcCtD
Nicotine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00134	CcSEcCtD
Nicotine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00133	CcSEcCtD
Nicotine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00133	CcSEcCtD
Nicotine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00133	CcSEcCtD
Nicotine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00133	CcSEcCtD
Nicotine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00133	CcSEcCtD
Nicotine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Nicotine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Nicotine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Nicotine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Nicotine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Nicotine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Nicotine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00131	CcSEcCtD
Nicotine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.0013	CcSEcCtD
Nicotine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000115	0.0013	CcSEcCtD
Nicotine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000115	0.0013	CcSEcCtD
Nicotine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000115	0.0013	CcSEcCtD
Nicotine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.0013	CcSEcCtD
Nicotine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.0013	CcSEcCtD
Nicotine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.00129	CcSEcCtD
Nicotine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00128	CcSEcCtD
Nicotine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00128	CcSEcCtD
Nicotine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00126	CcSEcCtD
Nicotine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00126	CcSEcCtD
Nicotine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00124	CcSEcCtD
Nicotine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00124	CcSEcCtD
Nicotine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00011	0.00124	CcSEcCtD
Nicotine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00124	CcSEcCtD
Nicotine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00123	CcSEcCtD
Nicotine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00123	CcSEcCtD
Nicotine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00123	CcSEcCtD
Nicotine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.00122	CcSEcCtD
Nicotine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00121	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00121	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00121	CcSEcCtD
Nicotine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000107	0.0012	CcSEcCtD
Nicotine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.0012	CcSEcCtD
Nicotine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000106	0.0012	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00119	CcSEcCtD
Nicotine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00119	CcSEcCtD
Nicotine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00119	CcSEcCtD
Nicotine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00118	CcSEcCtD
Nicotine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00118	CcSEcCtD
Nicotine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00118	CcSEcCtD
Nicotine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00117	CcSEcCtD
Nicotine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.00117	CcSEcCtD
Nicotine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000104	0.00117	CcSEcCtD
Nicotine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00117	CcSEcCtD
Nicotine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.00117	CcSEcCtD
Nicotine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00116	CcSEcCtD
Nicotine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000102	0.00116	CcSEcCtD
Nicotine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00115	CcSEcCtD
Nicotine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000102	0.00115	CcSEcCtD
Nicotine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.00115	CcSEcCtD
Nicotine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00115	CcSEcCtD
Nicotine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.00115	CcSEcCtD
Nicotine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000102	0.00115	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00114	CcSEcCtD
Nicotine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00114	CcSEcCtD
Nicotine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00114	CcSEcCtD
Nicotine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00114	CcSEcCtD
Nicotine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00114	CcSEcCtD
Nicotine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00114	CcSEcCtD
Nicotine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00113	CcSEcCtD
Nicotine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00113	CcSEcCtD
Nicotine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	9.99e-05	0.00113	CcSEcCtD
Nicotine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	9.96e-05	0.00113	CcSEcCtD
Nicotine—Fatigue—Montelukast—chronic obstructive pulmonary disease	9.95e-05	0.00112	CcSEcCtD
Nicotine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	9.92e-05	0.00112	CcSEcCtD
Nicotine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	9.89e-05	0.00112	CcSEcCtD
Nicotine—Pain—Montelukast—chronic obstructive pulmonary disease	9.87e-05	0.00111	CcSEcCtD
Nicotine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	9.84e-05	0.00111	CcSEcCtD
Nicotine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	9.79e-05	0.00111	CcSEcCtD
Nicotine—Rash—Aminophylline—chronic obstructive pulmonary disease	9.76e-05	0.0011	CcSEcCtD
Nicotine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	9.75e-05	0.0011	CcSEcCtD
Nicotine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	9.71e-05	0.0011	CcSEcCtD
Nicotine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	9.71e-05	0.0011	CcSEcCtD
Nicotine—Headache—Aminophylline—chronic obstructive pulmonary disease	9.7e-05	0.0011	CcSEcCtD
Nicotine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.00109	CcSEcCtD
Nicotine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.65e-05	0.00109	CcSEcCtD
Nicotine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.63e-05	0.00109	CcSEcCtD
Nicotine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.63e-05	0.00109	CcSEcCtD
Nicotine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	9.6e-05	0.00108	CcSEcCtD
Nicotine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.59e-05	0.00108	CcSEcCtD
Nicotine—Pain—Salbutamol—chronic obstructive pulmonary disease	9.51e-05	0.00107	CcSEcCtD
Nicotine—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.51e-05	0.00107	CcSEcCtD
Nicotine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.44e-05	0.00107	CcSEcCtD
Nicotine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.36e-05	0.00106	CcSEcCtD
Nicotine—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.36e-05	0.00106	CcSEcCtD
Nicotine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.31e-05	0.00105	CcSEcCtD
Nicotine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.31e-05	0.00105	CcSEcCtD
Nicotine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.31e-05	0.00105	CcSEcCtD
Nicotine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.31e-05	0.00105	CcSEcCtD
Nicotine—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.00105	CcSEcCtD
Nicotine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.28e-05	0.00105	CcSEcCtD
Nicotine—Rash—Tiotropium—chronic obstructive pulmonary disease	9.21e-05	0.00104	CcSEcCtD
Nicotine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.2e-05	0.00104	CcSEcCtD
Nicotine—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.2e-05	0.00104	CcSEcCtD
Nicotine—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.17e-05	0.00104	CcSEcCtD
Nicotine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.17e-05	0.00104	CcSEcCtD
Nicotine—Headache—Tiotropium—chronic obstructive pulmonary disease	9.15e-05	0.00103	CcSEcCtD
Nicotine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.12e-05	0.00103	CcSEcCtD
Nicotine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.12e-05	0.00103	CcSEcCtD
Nicotine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.1e-05	0.00103	CcSEcCtD
Nicotine—Irritability—Prednisone—chronic obstructive pulmonary disease	9e-05	0.00102	CcSEcCtD
Nicotine—Mood swings—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.00101	CcSEcCtD
Nicotine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.84e-05	0.000998	CcSEcCtD
Nicotine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.79e-05	0.000993	CcSEcCtD
Nicotine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.79e-05	0.000993	CcSEcCtD
Nicotine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.68e-05	0.000981	CcSEcCtD
Nicotine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.68e-05	0.000981	CcSEcCtD
Nicotine—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.67e-05	0.00098	CcSEcCtD
Nicotine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	8.66e-05	0.000978	CcSEcCtD
Nicotine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.5e-05	0.00096	CcSEcCtD
Nicotine—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.45e-05	0.000955	CcSEcCtD
Nicotine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.45e-05	0.000955	CcSEcCtD
Nicotine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.34e-05	0.000942	CcSEcCtD
Nicotine—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.34e-05	0.000942	CcSEcCtD
Nicotine—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.28e-05	0.000935	CcSEcCtD
Nicotine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.2e-05	0.000926	CcSEcCtD
Nicotine—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.16e-05	0.000922	CcSEcCtD
Nicotine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.06e-05	0.000911	CcSEcCtD
Nicotine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.06e-05	0.000911	CcSEcCtD
Nicotine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.02e-05	0.000906	CcSEcCtD
Nicotine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.98e-05	0.000902	CcSEcCtD
Nicotine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000897	CcSEcCtD
Nicotine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	7.9e-05	0.000892	CcSEcCtD
Nicotine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	7.87e-05	0.000889	CcSEcCtD
Nicotine—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.82e-05	0.000883	CcSEcCtD
Nicotine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.79e-05	0.00088	CcSEcCtD
Nicotine—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.79e-05	0.00088	CcSEcCtD
Nicotine—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.63e-05	0.000862	CcSEcCtD
Nicotine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.61e-05	0.00086	CcSEcCtD
Nicotine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.49e-05	0.000846	CcSEcCtD
Nicotine—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.49e-05	0.000846	CcSEcCtD
Nicotine—Rash—Formoterol—chronic obstructive pulmonary disease	7.43e-05	0.000839	CcSEcCtD
Nicotine—Rash—Arformoterol—chronic obstructive pulmonary disease	7.43e-05	0.000839	CcSEcCtD
Nicotine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.42e-05	0.000838	CcSEcCtD
Nicotine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.42e-05	0.000838	CcSEcCtD
Nicotine—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000838	CcSEcCtD
Nicotine—Headache—Formoterol—chronic obstructive pulmonary disease	7.38e-05	0.000834	CcSEcCtD
Nicotine—Headache—Arformoterol—chronic obstructive pulmonary disease	7.38e-05	0.000834	CcSEcCtD
Nicotine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.36e-05	0.000831	CcSEcCtD
Nicotine—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.34e-05	0.000829	CcSEcCtD
Nicotine—Rash—Montelukast—chronic obstructive pulmonary disease	7.28e-05	0.000822	CcSEcCtD
Nicotine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.27e-05	0.000821	CcSEcCtD
Nicotine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.25e-05	0.000819	CcSEcCtD
Nicotine—Headache—Montelukast—chronic obstructive pulmonary disease	7.23e-05	0.000817	CcSEcCtD
Nicotine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.14e-05	0.000807	CcSEcCtD
Nicotine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.07e-05	0.000799	CcSEcCtD
Nicotine—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.05e-05	0.000796	CcSEcCtD
Nicotine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.02e-05	0.000793	CcSEcCtD
Nicotine—Rash—Salbutamol—chronic obstructive pulmonary disease	7.01e-05	0.000792	CcSEcCtD
Nicotine—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.01e-05	0.000792	CcSEcCtD
Nicotine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.01e-05	0.000792	CcSEcCtD
Nicotine—Nausea—Formoterol—chronic obstructive pulmonary disease	7e-05	0.000791	CcSEcCtD
Nicotine—Nausea—Arformoterol—chronic obstructive pulmonary disease	7e-05	0.000791	CcSEcCtD
Nicotine—Headache—Salbutamol—chronic obstructive pulmonary disease	6.97e-05	0.000787	CcSEcCtD
Nicotine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.87e-05	0.000776	CcSEcCtD
Nicotine—Nausea—Montelukast—chronic obstructive pulmonary disease	6.85e-05	0.000774	CcSEcCtD
Nicotine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.77e-05	0.000765	CcSEcCtD
Nicotine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.75e-05	0.000762	CcSEcCtD
Nicotine—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.61e-05	0.000746	CcSEcCtD
Nicotine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.58e-05	0.000743	CcSEcCtD
Nicotine—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.38e-05	0.000721	CcSEcCtD
Nicotine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.38e-05	0.000721	CcSEcCtD
Nicotine—Shock—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.000709	CcSEcCtD
Nicotine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.23e-05	0.000703	CcSEcCtD
Nicotine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.17e-05	0.000697	CcSEcCtD
Nicotine—Flushing—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.000684	CcSEcCtD
Nicotine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000666	CcSEcCtD
Nicotine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000659	CcSEcCtD
Nicotine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.77e-05	0.000652	CcSEcCtD
Nicotine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.73e-05	0.000647	CcSEcCtD
Nicotine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.000646	CcSEcCtD
Nicotine—Erythema—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.000642	CcSEcCtD
Nicotine—Pain—Prednisolone—chronic obstructive pulmonary disease	5.46e-05	0.000616	CcSEcCtD
Nicotine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.000595	CcSEcCtD
Nicotine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.26e-05	0.000594	CcSEcCtD
Nicotine—Agitation—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.00059	CcSEcCtD
Nicotine—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000586	CcSEcCtD
Nicotine—Malaise—Prednisone—chronic obstructive pulmonary disease	5.12e-05	0.000579	CcSEcCtD
Nicotine—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000577	CcSEcCtD
Nicotine—Syncope—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000576	CcSEcCtD
Nicotine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.07e-05	0.000573	CcSEcCtD
Nicotine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000564	CcSEcCtD
Nicotine—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000556	CcSEcCtD
Nicotine—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000554	CcSEcCtD
Nicotine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000546	CcSEcCtD
Nicotine—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000546	CcSEcCtD
Nicotine—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000544	CcSEcCtD
Nicotine—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.00054	CcSEcCtD
Nicotine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.7e-05	0.000531	CcSEcCtD
Nicotine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000524	CcSEcCtD
Nicotine—Oedema—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000524	CcSEcCtD
Nicotine—Shock—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000515	CcSEcCtD
Nicotine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.55e-05	0.000514	CcSEcCtD
Nicotine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000511	CcSEcCtD
Nicotine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000506	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000477	CcSEcCtD
Nicotine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.22e-05	0.000477	CcSEcCtD
Nicotine—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000474	CcSEcCtD
Nicotine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.00047	CcSEcCtD
Nicotine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000461	CcSEcCtD
Nicotine—Rash—Prednisolone—chronic obstructive pulmonary disease	4.02e-05	0.000454	CcSEcCtD
Nicotine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.02e-05	0.000454	CcSEcCtD
Nicotine—Fatigue—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000452	CcSEcCtD
Nicotine—Headache—Prednisolone—chronic obstructive pulmonary disease	4e-05	0.000452	CcSEcCtD
Nicotine—Constipation—Prednisone—chronic obstructive pulmonary disease	3.97e-05	0.000448	CcSEcCtD
Nicotine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.82e-05	0.000432	CcSEcCtD
Nicotine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000428	CcSEcCtD
Nicotine—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.79e-05	0.000428	CcSEcCtD
Nicotine—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.68e-05	0.000416	CcSEcCtD
Nicotine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000414	CcSEcCtD
Nicotine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000414	CcSEcCtD
Nicotine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.000386	CcSEcCtD
Nicotine—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.33e-05	0.000376	CcSEcCtD
Nicotine—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.28e-05	0.000371	CcSEcCtD
Nicotine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.17e-05	0.000358	CcSEcCtD
Nicotine—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000346	CcSEcCtD
Nicotine—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.95e-05	0.000333	CcSEcCtD
Nicotine—Rash—Prednisone—chronic obstructive pulmonary disease	2.92e-05	0.00033	CcSEcCtD
Nicotine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.92e-05	0.00033	CcSEcCtD
Nicotine—Headache—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.000328	CcSEcCtD
Nicotine—Nausea—Prednisone—chronic obstructive pulmonary disease	2.75e-05	0.000311	CcSEcCtD
Nicotine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.91e-06	7.51e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.91e-06	7.51e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	7.86e-06	7.46e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.85e-06	7.45e-05	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	7.84e-06	7.44e-05	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	7.84e-06	7.44e-05	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.8e-06	7.41e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.74e-06	7.35e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.7e-06	7.3e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.63e-06	7.24e-05	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.61e-06	7.23e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	7.53e-06	7.15e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.51e-06	7.13e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	7.5e-06	7.12e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	7.42e-06	7.04e-05	CbGpPWpGaD
Nicotine—CHAT—Metabolism—ALB—chronic obstructive pulmonary disease	7.29e-06	6.92e-05	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.22e-06	6.85e-05	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.17e-06	6.81e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.12e-06	6.76e-05	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.1e-06	6.74e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.07e-06	6.71e-05	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.06e-06	6.7e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.04e-06	6.68e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	7.02e-06	6.66e-05	CbGpPWpGaD
Nicotine—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	7.01e-06	6.66e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7e-06	6.65e-05	CbGpPWpGaD
Nicotine—CHAT—Metabolism—NOS3—chronic obstructive pulmonary disease	6.98e-06	6.62e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GCLC—chronic obstructive pulmonary disease	6.96e-06	6.6e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.91e-06	6.56e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.9e-06	6.55e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.9e-06	6.55e-05	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.8e-06	6.45e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.7e-06	6.36e-05	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.46e-06	6.13e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	6.46e-06	6.13e-05	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.44e-06	6.12e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	6.4e-06	6.07e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CTGF—chronic obstructive pulmonary disease	6.35e-06	6.03e-05	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—ALB—chronic obstructive pulmonary disease	6.2e-06	5.89e-05	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.17e-06	5.85e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.15e-06	5.84e-05	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.15e-06	5.84e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.12e-06	5.8e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.03e-06	5.72e-05	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.02e-06	5.72e-05	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6e-06	5.7e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	5.98e-06	5.68e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.94e-06	5.64e-05	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—NOS3—chronic obstructive pulmonary disease	5.93e-06	5.63e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	5.86e-06	5.56e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.85e-06	5.55e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.77e-06	5.47e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.69e-06	5.4e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.68e-06	5.39e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.63e-06	5.35e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.61e-06	5.32e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.56e-06	5.28e-05	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.53e-06	5.25e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	5.53e-06	5.25e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	5.47e-06	5.19e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.46e-06	5.18e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.45e-06	5.17e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.3e-06	5.03e-05	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.25e-06	4.98e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.22e-06	4.95e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.21e-06	4.94e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.17e-06	4.91e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.17e-06	4.9e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	5.16e-06	4.9e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.14e-06	4.88e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.09e-06	4.83e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	5.07e-06	4.81e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.03e-06	4.78e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.02e-06	4.77e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5e-06	4.75e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.88e-06	4.63e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.81e-06	4.57e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.71e-06	4.47e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	4.71e-06	4.47e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.69e-06	4.45e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.65e-06	4.41e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.61e-06	4.38e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.59e-06	4.36e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.56e-06	4.33e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.52e-06	4.29e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.48e-06	4.26e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.41e-06	4.19e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.36e-06	4.14e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.34e-06	4.12e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.28e-06	4.06e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.25e-06	4.03e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.24e-06	4.02e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.23e-06	4.02e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.22e-06	4.01e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.2e-06	3.99e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.2e-06	3.99e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	4.16e-06	3.95e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.12e-06	3.91e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.11e-06	3.91e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.07e-06	3.86e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.05e-06	3.85e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.01e-06	3.8e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.98e-06	3.78e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.9e-06	3.7e-05	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.87e-06	3.67e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.87e-06	3.67e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.83e-06	3.64e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.75e-06	3.56e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.71e-06	3.52e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.67e-06	3.48e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.66e-06	3.47e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.62e-06	3.44e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.62e-06	3.43e-05	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.61e-06	3.42e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.57e-06	3.39e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.53e-06	3.35e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	3.52e-06	3.35e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.48e-06	3.3e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.42e-06	3.25e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	3.41e-06	3.24e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.37e-06	3.2e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.35e-06	3.18e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.32e-06	3.16e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.28e-06	3.11e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.27e-06	3.1e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	3.27e-06	3.1e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.24e-06	3.08e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.23e-06	3.07e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.2e-06	3.04e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.17e-06	3e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.15e-06	2.99e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.07e-06	2.92e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.06e-06	2.9e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.05e-06	2.9e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.02e-06	2.87e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.02e-06	2.86e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.98e-06	2.83e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.95e-06	2.8e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	2.89e-06	2.74e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.89e-06	2.74e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.85e-06	2.71e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.81e-06	2.67e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.81e-06	2.67e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.81e-06	2.67e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.8e-06	2.65e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.78e-06	2.64e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.77e-06	2.63e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.77e-06	2.63e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	2.76e-06	2.62e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.74e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.72e-06	2.59e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.72e-06	2.58e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.72e-06	2.58e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.67e-06	2.53e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.66e-06	2.53e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.62e-06	2.49e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.61e-06	2.48e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.58e-06	2.45e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.55e-06	2.42e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.53e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.51e-06	2.38e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.5e-06	2.37e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.48e-06	2.36e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.47e-06	2.35e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.45e-06	2.32e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.44e-06	2.32e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.3e-06	2.18e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.28e-06	2.16e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.27e-06	2.16e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.27e-06	2.15e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.25e-06	2.14e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.25e-06	2.13e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.24e-06	2.12e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.23e-06	2.12e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.23e-06	2.11e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.22e-06	2.11e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.19e-06	2.08e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	2.14e-06	2.03e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.09e-06	1.99e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.09e-06	1.98e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.08e-06	1.98e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.08e-06	1.97e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.06e-06	1.96e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.05e-06	1.95e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.05e-06	1.95e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	2.05e-06	1.95e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.04e-06	1.94e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.03e-06	1.93e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2e-06	1.9e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.97e-06	1.87e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.93e-06	1.84e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.93e-06	1.83e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.92e-06	1.83e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.92e-06	1.82e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.9e-06	1.81e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.89e-06	1.8e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-06	1.79e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.87e-06	1.78e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.81e-06	1.72e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.77e-06	1.68e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.76e-06	1.67e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.74e-06	1.65e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.73e-06	1.65e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.71e-06	1.63e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-06	1.6e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.69e-06	1.6e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.67e-06	1.59e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.66e-06	1.58e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.62e-06	1.53e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.59e-06	1.51e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.58e-06	1.5e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.57e-06	1.49e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.56e-06	1.48e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.55e-06	1.47e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.54e-06	1.46e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-06	1.42e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-06	1.41e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-06	1.39e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-06	1.37e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.43e-06	1.36e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-06	1.3e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.36e-06	1.29e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.34e-06	1.27e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-06	1.27e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.33e-06	1.27e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.32e-06	1.25e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.31e-06	1.25e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-06	1.22e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.26e-06	1.19e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-06	1.18e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.23e-06	1.17e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.23e-06	1.16e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-06	1.13e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-06	1.1e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.14e-06	1.08e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.09e-06	1.03e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-06	9.78e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-06	9.64e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-06	9.63e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	9.7e-07	9.21e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.46e-07	8.98e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	9.33e-07	8.85e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	9.25e-07	8.78e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.97e-07	8.52e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.92e-07	8.47e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.85e-07	8.4e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	7.9e-07	7.5e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.56e-07	7.17e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.1e-07	5.79e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.83e-07	5.54e-06	CbGpPWpGaD
